GO:0004687 myosin light chain kinase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0004687 myosin light chain kinase activity describes the ATP-dependent phosphorylation of myosin light chains, a central switch for actomyosin contractility.
• MLCK activity is calcium/calmodulin-dependent and is best known for regulating smooth muscle contraction and non-muscle myosin II function.
• Beyond contraction, MLCK-driven phosphorylation controls epithelial and endothelial barrier permeability, mucosal homeostasis, and mitotic actin cortex dynamics.
• Dysregulated MLCK activity is implicated in Crohn's disease, endothelial barrier dysfunction, and cardiac systolic dysfunction.
• Key experimental models include MLCK knockout, kinase-dead point mutants, phospho-mimetic knock-ins, and tagged knock-ins for imaging.
• CRISPR-based editing enables causal dissection of MLCK substrate specificity, isoform function, and disease-relevant phosphorylation events.
Description
Myosin light chain kinase (MLCK) activity, annotated as GO:0004687, is the catalytic function that transfers the gamma-phosphate of ATP to a myosin light chain substrate, producing ADP and phosphorylated myosin light chain. This activity is a canonical calcium/calmodulin-dependent protein kinase reaction and is widely recognized as the molecular trigger for smooth muscle contraction and non-muscle myosin II activation. Because myosin light chain phosphorylation governs actomyosin cross-bridge cycling, MLCK activity sits at the intersection of muscle physiology, cell motility, and barrier regulation. Researchers study GO:0004687 to understand how cells convert chemical energy and calcium signals into mechanical force, and how this conversion goes awry in disease. The term is distinct from other kinase activities because its defining substrate is the myosin light chain, and its regulation is tightly coupled to calmodulin and to site-specific phosphorylation of myosin regulatory light chains. In epithelial and endothelial cells, MLCK activity controls paracellular permeability and mucosal homeostasis, making it a target of interest in inflammatory and barrier-related disorders. In the heart, cardiac MLCK activity influences myosin super-relaxation and systolic performance, linking the enzyme to contractile dysfunction. In dividing cells, MLCK-driven myosin II turnover shapes actin cortex contractility during mitosis. This article synthesizes the QuickGO definition and verified literature to provide a research-grade overview of MLCK activity, its genes, regulation, disease relevance, and the CRISPR and omics methods used to study it.
myosin light chain kinase activity At A Glance
| GO ID | GO:0004687 |
|---|---|
| GO term | myosin light chain kinase activity |
| Ontology | molecular_function |
| Synonym | MLCK; myosin kinase activity; calcium/calmodulin-dependent myosin light chain kinase activity; smooth-muscle-myosin-light-chain kinase activity; STK18 |
| Major function | ATP-dependent phosphorylation of myosin light chains to regulate actomyosin contractility |
| Reaction | ATP + myosin-light-chain = ADP + myosin-light-chain phosphate |
| Cofactor/regulator | Calcium/calmodulin-dependent activation |
| Substrate | Myosin regulatory light chain |
| Related processes | Smooth muscle contraction, non-muscle myosin II activation, barrier permeability, mitosis |
What Is GO:0004687?
GO:0004687 myosin light chain kinase activity is a molecular function defined by the catalysis of the reaction ATP + myosin-light-chain = ADP + myosin-light-chain phosphate. In practical terms, it is the enzymatic activity that phosphorylates myosin light chains using ATP, and it is synonymous with MLCK, myosin kinase, smooth-muscle-myosin-light-chain kinase, and calcium/calmodulin-dependent myosin light chain kinase activity. The activity is typically calcium/calmodulin-dependent and is mediated by enzymes of the myosin light chain kinase family.
Why Is myosin light chain kinase activity Important in Cell Biology?
Myosin light chain kinase activity is important because it is the direct enzymatic step that converts calcium/calmodulin signals into myosin light chain phosphorylation, thereby controlling actomyosin contractility in muscle and non-muscle cells. This activity regulates smooth muscle contraction, epithelial and endothelial barrier function, mucosal homeostasis, cardiac contractility, and mitotic cell shape changes. Because dysregulated MLCK activity is associated with Crohn's disease, endothelial barrier dysfunction, and systolic dysfunction, it is a high-value target for mechanistic and therapeutic research.
• Controls smooth muscle contraction through calcium/calmodulin-dependent myosin light chain phosphorylation.
• Regulates non-muscle myosin II and actin cortex contractility during mitosis.
• Maintains epithelial paracellular permeability and mucosal homeostasis.
• Modulates endothelial barrier function and vascular permeability.
• Influences cardiac myosin super-relaxation and systolic performance.
• Is implicated in inflammatory barrier disorders such as Crohn's disease.
• Provides a druggable node for contractility-related pathologies.
• Serves as a model kinase for studying calmodulin-dependent regulation.
• Connects cytoskeletal dynamics to cell shape, motility, and tissue integrity.
• Enables CRISPR-based causal studies of phosphorylation site function.
What Happens During myosin light chain kinase activity?
Calcium/calmodulin activation
In simple terms: Calcium binds calmodulin, which then switches MLCK on.
MLCK activity is classically activated by calcium-bound calmodulin, which relieves autoinhibition and allows the kinase domain to access myosin light chain substrates. This calcium/calmodulin dependence is a defining regulatory feature of the enzyme and couples contractile signals to intracellular calcium transients.
ATP-dependent phosphorylation of myosin light chain
In simple terms: The active kinase uses ATP to attach a phosphate onto myosin light chains.
Once active, MLCK catalyzes the transfer of the terminal phosphate from ATP to a specific serine or threonine residue on the myosin regulatory light chain, generating ADP and phosphorylated myosin light chain. This phosphorylation event is the core reaction of GO:0004687 and is required for myosin II activation.
Actomyosin contraction and force generation
In simple terms: Phosphorylated myosin light chains let myosin pull on actin, producing force.
Phosphorylated myosin light chains promote cross-bridge cycling with actin filaments, driving smooth muscle contraction and non-muscle cell contractility. In smooth muscle, this activity is a primary determinant of contractile tone, while in non-muscle cells it shapes cortical tension and motility.
Barrier and junctional regulation
In simple terms: MLCK activity can pull on cell junctions and change how leaky a cell layer is.
In epithelial and endothelial monolayers, MLCK-driven myosin light chain phosphorylation alters actomyosin tension at cell-cell junctions, thereby modulating paracellular permeability and mucosal homeostasis. This function links GO:0004687 to barrier integrity in inflammatory and vascular contexts.
Mitotic actin cortex dynamics
In simple terms: During cell division, MLCK helps myosin turn over to keep the actin cortex contractile.
MLCK-driven myosin II turnover regulates actin cortex contractility during mitosis, contributing to cell rounding and division. This non-muscle role highlights that GO:0004687 is not restricted to muscle contraction but also operates in proliferating cells.
Key Genes Involved in GO:0004687 myosin light chain kinase activity
The following genes and proteins are central to myosin light chain kinase activity, its regulation, and its downstream contractile functions.
| Gene | Major Role | Research Relevance |
|---|---|---|
| MYLK | Encodes smooth muscle and non-muscle myosin light chain kinase isoforms | Core enzyme for GO:0004687; knockout and point-mutant models |
| MYLK2 | Encodes skeletal muscle myosin light chain kinase | Muscle-specific regulation of myosin light chain phosphorylation |
| MYLK3 | Encodes cardiac myosin light chain kinase | Cardiac contractility and super-relaxed myosin studies |
| MYL9 | Myosin regulatory light chain in smooth muscle | Primary substrate for MLCK phosphorylation |
| MYL12A | Non-muscle myosin regulatory light chain | Substrate in epithelial and endothelial cells |
| MYL12B | Non-muscle myosin regulatory light chain | Substrate in barrier and mitotic studies |
| MYH9 | Non-muscle myosin heavy chain IIA | Effector of MLCK-driven contractility |
| MYH10 | Non-muscle myosin heavy chain IIB | Effector in cortical and junctional tension |
| CALM1 | Calmodulin, calcium sensor | Required for calcium/calmodulin-dependent MLCK activation |
| CALM2 | Calmodulin, calcium sensor | Regulates MLCK activity |
| CALM3 | Calmodulin, calcium sensor | Regulates MLCK activity |
| ACTB | Actin cytoskeleton component | Partner for actomyosin contraction downstream of MLCK |
| ACTG1 | Actin cytoskeleton component | Cytoskeletal context of MLCK activity |
| ROCK1 | Rho kinase, indirect regulator of myosin light chain phosphorylation | Modulates contractility alongside MLCK |
| ROCK2 | Rho kinase, indirect regulator of myosin light chain phosphorylation | Modulates contractility alongside MLCK |
| PPP1R12A | Myosin light chain phosphatase regulatory subunit | Opposes MLCK activity to set phosphorylation balance |
| MYPT1 | Myosin phosphatase target subunit | Regulates dephosphorylation of myosin light chain |
How Is myosin light chain kinase activity Regulated?
MLCK activity is regulated primarily by calcium/calmodulin binding, which relieves autoinhibition and enables substrate phosphorylation. The phosphorylation state of myosin light chains reflects a balance between MLCK activity and myosin light chain phosphatase activity, so regulatory inputs that alter either enzyme change contractile output. In endothelial and epithelial contexts, MLCK signaling is modulated by inflammatory and permeability-related pathways that influence barrier function. In the heart, cardiac MLCK activity is linked to myosin super-relaxation and systolic performance, indicating that its regulation is physiologically consequential beyond smooth muscle. During mitosis, MLCK-driven myosin II turnover is coordinated with cell cycle progression to control actin cortex contractility.
myosin light chain kinase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| MYLK | Crohn's disease and intestinal barrier dysfunction | Intestinal epithelial knockout or point-mutant models |
| MYLK | Endothelial barrier dysfunction | Endothelial knockout and permeability assays |
| MYLK3 | Cardiac systolic dysfunction | Cardiac knock-in or overexpression models |
| MYL9 | Smooth muscle contractile disorders | Phospho-site knock-in and knockout models |
| MYL12A/MYL12B | Epithelial and mitotic contractility defects | Non-muscle knockout and tagged knock-in models |
Crohn's disease and mucosal barrier dysfunction
MLCK regulates intestinal permeability and mucosal homeostasis, and dysregulated MLCK activity is implicated in the barrier defects associated with Crohn's disease. Epithelial paracellular permeability is directly influenced by MLCK-mediated myosin light chain phosphorylation, making this activity a mechanistic node in inflammatory bowel disease research.
Endothelial barrier dysfunction and vascular permeability
MLCK signaling contributes to endothelial barrier dysfunction, where increased myosin light chain phosphorylation promotes actomyosin contraction and junctional disruption. This links GO:0004687 to vascular leak in inflammatory and pathological settings.
Cardiac systolic dysfunction
Restoration of cardiac myosin light chain kinase ameliorates systolic dysfunction by reducing superrelaxed myosin, demonstrating that cardiac MLCK activity is functionally important for contractile performance. This positions cardiac MLCK as a potential target for heart failure research.
Mitotic and proliferative cell biology
MLCK-driven myosin II turnover regulates actin cortex contractility during mitosis, so altered MLCK activity could influence cell division and proliferation. This connection broadens the disease relevance of GO:0004687 to proliferative and cytoskeletal disorders.
From myosin light chain kinase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is MLCK catalytic activity required for smooth muscle contraction? | MYLK knockout or kinase-dead point mutation |
| Does cardiac MLCK restoration improve systolic function? | Cardiac MYLK3 overexpression or knock-in |
| Which myosin light chain phosphorylation sites mediate barrier regulation? | Phospho-mimetic or phospho-dead knock-in of MYL9/MYL12 |
| How does MLCK activity affect mitotic actin cortex dynamics? | Tagged knock-in of MLCK with live imaging |
| What is the balance between MLCK and myosin phosphatase? | Knockout of PPP1R12A combined with MLCK perturbation |
| Does MLCK activity control epithelial permeability in vivo? | Intestinal epithelial conditional knockout |
How to Study the myosin light chain kinase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| In vitro kinase assay | ATP consumption or phosphate incorporation | Direct quantification of MLCK activity |
| Phospho-Western blot | Myosin light chain phosphorylation state | Pathway activation in cells and tissues |
| Immunofluorescence | Subcellular localization of phospho-myosin | Contractile structure analysis |
| Live-cell imaging | Actomyosin dynamics and cortical contractility | Mitotic and migratory studies |
| TEER/tracer flux | Epithelial and endothelial barrier permeability | Mucosal and vascular barrier research |
| CRISPR knockout | Loss-of-function phenotype | Causal gene function studies |
| Phospho-mimetic knock-in | Effect of constitutive phosphorylation | Substrate site dissection |
| Proteomics | Global phosphorylation changes | Pathway mapping downstream of MLCK |
Kinase activity assays
In vitro kinase assays using purified MLCK and myosin light chain substrates measure ATP consumption or phosphate incorporation to quantify GO:0004687 activity directly. These assays are foundational for determining specific activity, calcium/calmodulin dependence, and inhibitor sensitivity.
Phospho-specific immunodetection
Western blotting and immunofluorescence with phospho-myosin light chain antibodies report the phosphorylation state downstream of MLCK activity in cells and tissues. This approach is widely used to link MLCK activity to barrier, contractile, and cardiac phenotypes.
Live-cell imaging of contractility
Live imaging of actin and myosin reporters visualizes actomyosin dynamics and cortical contractility regulated by MLCK activity, including during mitosis. Tagged knock-in models enable tracking of MLCK localization and turnover in real time.
Permeability and barrier assays
Transepithelial or transendothelial electrical resistance and tracer flux assays measure barrier function controlled by MLCK activity in epithelial and endothelial monolayers. These functional readouts connect molecular phosphorylation events to tissue-level permeability.
How CRISPR Can Be Used to Study GO:0004687 myosin light chain kinase activity
Knockout
CRISPR knockout of MYLK or related myosin light chain genes eliminates MLCK activity and reveals its requirement for contraction, barrier function, and mitosis. Knockout models are essential for distinguishing catalytic activity from non-kinase functions of MLCK.
Point Mutation
Point mutations that disable catalytic activity or alter calcium/calmodulin regulation allow precise testing of GO:0004687 without confounding protein loss. Phospho-site mutations in myosin light chains can also be introduced to test downstream signaling.
Knock-in
Knock-in of phospho-mimetic or phospho-dead myosin light chain alleles, or tagged MLCK alleles, enables controlled interrogation of phosphorylation-dependent functions and live imaging. Cardiac MLCK knock-in and restoration studies illustrate the power of this approach for contractile phenotypes.
Overexpression
Overexpression of MLCK isoforms or constitutively active variants increases myosin light chain phosphorylation and contractility, useful for gain-of-function studies in barrier and cardiac models. Overexpression can also reveal dose-dependent effects on actomyosin dynamics.
How EDITGENE Supports myosin light chain kinase activity Research
Researchers studying myosin light chain kinase activity-related genes often need to determine whether a candidate gene is causally involved in contractility, barrier function, or disease phenotypes, and CRISPR-based models provide the most direct route to that answer. EDITGENE supports this work with end-to-end cell model engineering and screening services tailored to GO:0004687 biology.
Contact EDITGENE today to design your custom CRISPR model for myosin light chain kinase activity research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| MYLK Knockout Caco-2 Cell Line | EDJ-KQ11 | Human | 4638 | Details Get a Quote |
| MYLK3 Knockout HEK293 Cell Line | EDJ-KQ853 | Human | 91807 | Details Get a Quote |
| MYLK Knockout HEK293 Cell Line | EDJ-KQ1434 | Human | 4638 | Details Get a Quote |
| MYLK2 Knockout HEK293 Cell Line | EDJ-KQ1435 | Human | 85366 | Details Get a Quote |
| MYLK4 Knockout HEK293 Cell Line | EDJ-KQ1437 | Human | 340156 | Details Get a Quote |
| MYLK Knockout A-549 Cell Line | EDJ-KQ20978 | Human | 4638 | Details Get a Quote |
| MYLK Knockout HCT 116 Cell Line | EDJ-KQ20979 | Human | 4638 | Details Get a Quote |
| MYLK Knockout HeLa Cell Line | EDJ-KQ20980 | Human | 4638 | Details Get a Quote |
| MYLK2 Knockout HCT 116 Cell Line | EDJ-KQ20981 | Human | 85366 | Details Get a Quote |
| MYLK2 Knockout HeLa Cell Line | EDJ-KQ20982 | Human | 85366 | Details Get a Quote |
| MYLK3 Knockout HeLa Cell Line | EDJ-KQ20983 | Human | 91807 | Details Get a Quote |
| MYLK4 Knockout HeLa Cell Line | EDJ-KQ59668 | Human | 340156 | Details Get a Quote |
| MYLK2 Knockout A-549 Cell Line | EDJ-KQ66207 | Human | 85366 | Details Get a Quote |
| MYLK3 Knockout A-549 Cell Line | EDJ-KQ66309 | Human | 91807 | Details Get a Quote |
| MYLK4 Knockout A-549 Cell Line | EDJ-KQ68140 | Human | 340156 | Details Get a Quote |
Frequently Asked Questions About myosin light chain kinase activity
What is myosin light chain kinase activity?
Myosin light chain kinase activity (GO:0004687) is the ATP-dependent phosphorylation of myosin light chains, producing ADP and phosphorylated myosin light chain, and it is typically calcium/calmodulin-dependent.
What genes are involved in myosin light chain kinase activity?
Key genes include MYLK, MYLK2, MYLK3, the myosin light chain substrates MYL9, MYL12A, and MYL12B, calmodulin genes CALM1-3, and regulators such as PPP1R12A.
What is the GO ID for myosin light chain kinase activity?
The Gene Ontology ID is GO:0004687, under the molecular_function aspect.
How is myosin light chain kinase activity regulated?
It is regulated by calcium/calmodulin binding and balanced by myosin light chain phosphatase activity, with additional context-specific inputs in endothelial, epithelial, and cardiac cells.
What diseases are linked to myosin light chain kinase activity?
It has been linked to Crohn's disease, endothelial barrier dysfunction, and cardiac systolic dysfunction, among other contractility-related conditions.
How do you measure myosin light chain kinase activity?
Common methods include in vitro kinase assays, phospho-specific Western blotting, immunofluorescence, live-cell imaging, and barrier permeability assays.
What is the reaction catalyzed by myosin light chain kinase?
The reaction is ATP + myosin-light-chain = ADP + myosin-light-chain phosphate.
Is myosin light chain kinase activity only in muscle?
No, it also operates in non-muscle cells, where it regulates epithelial and endothelial barrier function and mitotic actin cortex contractility.
What are the synonyms for myosin light chain kinase activity?
Synonyms include MLCK, myosin kinase activity, calcium/calmodulin-dependent myosin light chain kinase activity, smooth-muscle-myosin-light-chain kinase activity, and STK18.
How can CRISPR help study myosin light chain kinase activity?
CRISPR knockout, point mutation, knock-in, and overexpression models allow causal testing of MLCK catalytic function, substrate phosphorylation, and disease-relevant phenotypes.
Conclusion
GO:0004687 myosin light chain kinase activity is a central molecular function that converts ATP and calcium/calmodulin signals into myosin light chain phosphorylation, driving smooth muscle contraction, non-muscle contractility, barrier regulation, and mitotic dynamics. Its dysregulation is associated with Crohn's disease, endothelial barrier dysfunction, and cardiac systolic dysfunction, making it a compelling target for mechanistic and translational research. CRISPR-based knockout, point-mutation, knock-in, and overexpression models, combined with kinase assays, phospho-imaging, and omics, provide a rigorous path to dissect this activity and its disease connections.
References
- 1. Yao Y et al.. 2020. Myosin light chain kinase regulates intestinal permeability of mucosal homeostasis in Crohn's disease.. Expert Rev Clin Immunol 16(12):1127-1141 PMID: 33183108
- 2. Nakamura A et al.. 2008. Role of non-kinase activity of myosin light-chain kinase in regulating smooth muscle contraction, a review dedicated to Dr. Setsuro Ebashi.. Biochem Biophys Res Commun 369(1):135-43 PMID: 18053800
- 3. Stull JT et al.. 1998. Myosin light chain kinase: functional domains and structural motifs.. Acta Physiol Scand 164(4):471-82 PMID: 9887970
- 4. Hitsumoto T et al.. 2023. Restoration of Cardiac Myosin Light Chain Kinase Ameliorates Systolic Dysfunction by Reducing Superrelaxed Myosin.. Circulation 147(25):1902-1918 PMID: 37128901
- 5. He WQ et al.. 2020. Contributions of Myosin Light Chain Kinase to Regulation of Epithelial Paracellular Permeability and Mucosal Homeostasis.. Int J Mol Sci 21(3) PMID: 32028590
- 6. Rigor RR et al.. 2013. Myosin light chain kinase signaling in endothelial barrier dysfunction.. Med Res Rev 33(5):911-33 PMID: 22886693
- 7. Taneja N et al.. 2021. Myosin light chain kinase-driven myosin II turnover regulates actin cortex contractility during mitosis.. Mol Biol Cell 32(20):br3 PMID: 34319762
- 8. Gallagher PJ et al.. 1997. Myosin light chain kinases.. J Muscle Res Cell Motil 18(1):1-16 PMID: 9147985
